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Background: A current prevalence and relevant risk factors for impaired fasting glucose (IFG) have been reported
by various ethnic groups and countries. By contrast, nationwide data for the incidence of IFG in Taiwan have not
been presented in the past 15 years. The aim for this manuscript was to estimate the prevalence of IFG and
associated risk factors in the population of Taiwan.
Methods: For this cross-sectional research, we used a nationally representative sample (N = 2604) obtained from
the 2005–2008 Nutrition and Health Survey in Taiwan (NAHSIT), and adopted a stratified multistage sampling
design. The tools employed for data collection included questionnaire interviews, anthropometry measurements,
and laboratory analysis.
Results: The prevalence of IFG among adults in Taiwan is 35.8% (a fasting glucose level between 100 and 125 mg/dl
is considered abnormal). An estimated number of people with IFG is 6.5 million. A higher prevalence of IFG is observed
in men younger than 65 years compared to women. However, this trend is reversed for the elderly population. The
factors significantly associated with IFG include the following: sex, age, overweight (27 > BMI ≥ 24), obesity (BMI ≥ 27),
waist circumference (men ≥ 90 cm, women ≥ 80 cm), hypertension, and hyperlipidemia.
Conclusions: IFG among adults in Taiwan is a health concern that requires attention. We recommend targeting the
younger population, especially overweight and obese men between the ages of 19 and 40 years, to provide applicable
healthy lifestyle counseling and services. Furthermore, appropriate screening of elderly people is required to detect
undiagnosed IFG cases and provide early intervention and treatment.
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Diabetes has become increasingly prevalent. According to
the International Diabetes Federation (IDF), approxi-
mately 366 million adults were diagnosed with diabetes in
2011, and 552 million adults are expected to be affected
by diabetes by 2030. In other words, the prevalence of dia-
betes is predicted to increase by 50.7% over a 19-y period
[1]. A survey conducted by Taiwanese researchers from
1993 to 1996 showed that the prevalence of diabetes
among people aged over 19 years was 5.3%. This rate in-
creased to 9.1% between 2005 and 2008, nearly double
that for 1993 to 1996 [2]. Thus, diabetes has become a
critical public health topic that demands global attention.
Furthermore, diabetes is associated with greater risks of* Correspondence: mchang@ntu.edu.tw
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reproduction in any medium, provided the orcapillary and macrovascular complications and premature
death [3]. Consequently, early screening to identify people
at high risk of diabetes is crucial for diabetes prevention.
Impaired fasting glucose (IFG) is a common glucose
disorder, and considered a state of prediabetes associated
with increased risk of diabetes [4]. IFG refers to a condi-
tion in which fasting blood glucose is elevated above
normal levels, although the abnormality has not reached
the threshold for a diagnosis of diabetes. Recently, IFG
has received increasingly widespread attention and is
considered a potentially crucial indicator for preventing
diabetes and cardiovascular diseases [5]. In 1997, the
American Diabetes Association (ADA) defined the
threshold for IFG as between 110 and 125 mg/dl [6]. In
addition to a substantially higher risk of type 2 diabetes
[7,8], a long-term state of abnormal blood glucose in-
creases the risk of cardiovascular disease, stroke, andal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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recommended that the threshold for a diagnosis of IFG
be reduced from the previous 110 mg/dl to 100 mg/dl
[4,9]. This was because people with a fasting blood glu-
cose level of between 100 and 109 exhibit a higher
prevalence of diabetes compared to people with a fasting
blood glucose level of <100 mg/dl. In addition, fasting
blood glucose levels are commonly used as an indicator
in clinical tests [10]. Thus, reducing the IFG threshold
can facilitate the early identification of people at high
risk of diabetes and the adoption of preventive measures
that delay the development of type 2 diabetes.
Contrary to the relative irreversibility of diabetes, IFG
can be treated using appropriate intervention measures,
thereby delaying or preventing diabetes [11]. Nonetheless,
because IFG does not typically present with clinical symp-
toms, confirmation and interventions should begin at an
earlier stage. A current prevalence and relevant risk factors
for IFG have been reported by various ethnic groups and
countries [12-18]. By contrast, nationwide data for the in-
cidence of IFG in Taiwan have not been presented in the
past 15 years [7,19]. Therefore, this research adopted the
new IFG diagnostic threshold (100–125 mg/dl) to analyze
data obtained from the nationwide Nutrition and Health
Survey in Taiwan (NAHSIT) for 2005 to 2008. The re-
search objectives were to understand the prevalence of
IFG among adults in Taiwan, and to explore the crucial
variables that influence Taiwanese adults’ IFG levels. The
results of an in-depth investigation of IFG prevalence in
Taiwan and other relevant factors can be compared with
international research to identify the potential causes of
IFG and provide a reference for the planning of future dia-
betes interventions.
Methods
We analyzed data from the NAHSIT, which adopted a
multistage, stratified clustering sampling scheme [2,20].
The NAHSIT is a national field survey conducted by Aca-
demia Sinica under the commission of the Ministry of
Health and Welfare, Executive Yuan, Taiwan. The NAHSIT
targets children aged 0 to 6 years and adults aged over
19 years who have Taiwanese citizenship, excluding resi-
dents of long-term care institutions. The questionnaire re-
sponse rate was 65%, and the physical examination rate was
59% [20-22]. The study design was previously employed
elsewhere [2,20]. The survey implementation and instru-
ments were approved by the Institutional Review Board of
Academia Sinica, which also conducted the survey, and re-
viewers from the Department of Health, Taiwan (DOH94-
FS-6–4). The NAHSIT is a cross-sectional and nationally
representative survey that was conducted from January 1,
2005, to December 31, 2008.
Briefly, 358 townships and city districts in Taiwan were
divided into 8 sampling strata according to urbanization,dietary patterns, and geographic location. These strata
comprised 2 in Northern Taiwan and one stratum each
for Central Taiwan, Southern Taiwan, Eastern Taiwan,
Hakka and mountainous areas, East Coast, and Peng-Hu
Islands. Using probabilities proportional to size, sex and
townships were selected in each stratum. Overall, 48
townships were chosen for the 8 strata, and 128 individ-
uals were sampled from the selected townships. An eli-
gible person’s probability of selection was based on his/her
registered area of residence, sex, and age. Appropriate
weights for each stratum were estimated based on the
total population in the stratum. This weighting was used
in all analyses of the participants’ characteristics included
in the questionnaire interview and health examination.
The total NAHSIT sample numbered 6144, comprising
1479 children and 4665 adults aged over 19 years. Among
the adult participants, 2808 underwent a physical examin-
ation and completed the survey questionnaire. This re-
search analyzed only data of these 2808 participants. After
adjusting for age, no major differences in the distribution
for sex and education level were observed between the par-
ticipants who had/had not completed the questionnaire
and the participants who had/had not undergone a physical
examination [20]. After excluding those who lacked FPG
values (N = 124) and provided incomplete data (N = 80),
2604 participants (1285 men and 1319 women) aged be-
tween 19 and 98 years remained.
Investigated measurements
The tools for data collection included questionnaire in-
terviews, anthropometric measurements, and laboratory
analysis.
Questionnaire data
The researchers administered a structured questionnaire
regarding demographic characteristics, namely, age, sex,
medical history, and drug consumption, to each participant.
Anthropometric data
The participants’ body mass index (BMI) was calculated
as weight (kg) divided by height squared (m). Waist cir-
cumference was measured at the narrowest point be-
tween the lower borders of the rib cage and iliac crest.
Blood pressure (BP) was measured using an Omega
1400 automatic blood pressure monitor. The systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
of each participant were measured 3 times using a mer-
cury sphygmomanometer, with the participants in a sit-
ting position, and after 15-min rest periods; the three
values were then averaged. Using BMI (as defined by the
Department of Health, Taiwan) as the standard for deter-
mining obesity, a BMI of 24 to 27 was regarded as over-
weight and a BMI ≥ 27 as obese [23]. In addition to BMI,
waist circumference was sued to indicate abdominal
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defined as a circumference ≥ 90 cm for men and ≥ 80 cm
for women [24].
Laboratory data
A fasting blood sample was obtained in the morning
after at least an 8-h fast. Laboratory data included levels
of fasting blood glucose, total cholesterol (TCHO), tri-
glycerides (TG), high-density lipoprotein (HDL), and
low-density lipoprotein (LDL).
Definition of IFG, hypertension, and hyperlipidemia
Regarding the definition of IFG adopted for this paper,
we referenced the 2003 ADA-revised threshold for nor-
mal FPG, abnormal FPG (ie, IFG or pre-diabetes), and
diabetes [4,9]. Normal FPG refers to an FPG level below
100 mg/dl, without a history of diabetic medication. IFG
refers to a level between 100 and 125 mg/dl with no
consumption of diabetic medication. Diabetes is mani-
fest when the FPG level equals or exceeds 126 mg/dl, or
a history of diabetic medication exists. In addition, we
defined hypertension according to the most recent cri-
teria established by the Joint National Committee/World
Health Organization (JNC7/WHO) in 2003; specifically,
a diagnosis of hypertension is confirmed when a patient’s
SBP equals or exceeds 140 mmHg, and/or the patient’s
DBP equals or exceeds 90 mmHg [25]. The participants
who reported a history of hypertension or current con-
sumption of antihypertensive medication during the survey
were classified as having hypertension. We defined hyper-
lipidemia based on the classification standard developed by
the Department of Health, Executive Yuan, Taiwan (2007),
which classifies dyslipidemia into the following three types:
(1) hypercholesterolemia, if TCHO ≥ 200 mg/dl; (2) mixed
hyperlipidemia, if TCHO ≥ 200 mg/dl and TG ≥ 200 mg/dl;
and (3) hypertriglyceridemia, if TG ≥ 200 mg/dl and
high-density lipoprotein cholesterol (HDL-C) < 40 mg/dl
or TCHO/HDL-C ≥ 5. Hyperlipidemia is manifest if any
of the aforementioned conditions are observed [26]. The
participants who reported a history of hyperlipidemia or
current consumption of hypolipidemic medication during
the survey were classified as having hyperlipidemia.
Statistical analysis
SPSS (Version 12.0; SPSS Inc., Chicago, Illinois, U.S.A.)
was used to conduct data analysis. For descriptive statis-
tics, categorical variables were described using frequency
distribution and percentage, and continuous variables
were described using the mean and standard deviation
(SD). For correlational statistics, we conducted an inde-
pendent samples t-test and a chi-square test. For infer-
ential statistics, logistic regression was performed to
examine IFG-related factors. The strength of association
between the dependent variables was assessed usingodds ratios (ORs). Finally, for multiple logistic regression
analysis using the backward stepwise conditional method,
we included variables found to have a statistically signifi-
cant association with the dependent variable. All tests con-
ducted in this research were two-tailed tests, and the level
of statistical correlation was set as α=0.05.
Results
Prevalence of IFG
A total of 2604 people participated in this research
(1285 men and 1319 women). The participants were
aged between 19 and 98 years (mean = 53.8 ± 17.4). Ac-
cording to the 2003 ADA-revised IFG diagnostic threshold
(100–125 mg/dl), the prevalence of normal FPG among
the participants was 55.7%, and that of IFG was 35.8%.
An estimated number of people with IFG is 6.5 million.
Overall, the prevalence of IFG was higher among men
(42.1%) than among women (29.6%), as shown in Table 1.
Furthermore, classifications for the 3 age groups according
to sex show that the prevalence of IFG ranged from
36.7% to 43.7% among young (19 to 40 years), middle-
aged (41 to 64 years), and elderly (age ≥ 65 years) men.
By contrast, the prevalence of IFG in women increased
with age and continued to rise among elderly women,
reaching 50.3% (Figure 1).
Associated factors
Compared to those with normal FPG levels, the partici-
pants with IFG tended to be older and had relatively
higher TCHO, TG, and LDL levels; greater SBP, DBP,
BMI, and waist circumference; and yet showed compara-
tively lower HDL levels. These data demonstrate the statis-
tically significant differences (P < 0.01) observed. Overall,
the overweight, obesity, abdominal obesity, hypertension,
and hyperlipidemia values for the participants with IFG
were significantly higher than those for the participants
with normal FPG levels (P < 0.01; Table 2).
OR of the factors associated with IFG
As shown in Table 3, the logistic regression analysis re-
sults indicated that the following variables significantly
influence IFG: sex, age, overweight (27 > BMI ≥ 24),
obesity (BMI ≥ 27), abdominal obesity (ie, waist circum-
ference; men ≥ 90 cm and women ≥ 80 cm), hyperten-
sion, and hyperlipidemia. The likelihood of IFG for men
exceeded that for women by 1.99 (95% CI = 1.99–2.00),
increasing by 1.03 for each additional year of age (95%
CI = 1.03–1.04). Classifications of BMI and waist circum-
ference based on the diagnostic criteria for metabolic
syndrome [20,21] indicate that compared to the partici-
pants who were not overweight, obese, or categorized as
abdominally obese, the participants who were overweight
(27 > BMI ≥ 24), obese (BMI ≥ 27), or categorized as ab-
dominally obese according to their waist circumference





1997 ADA definition as FPG 110-125 mg/dl 18435969 14931484(81.0) 1937615(10.5) 1566870(8.5)
2003 ADA definition as FPG 100-125 mg/dl 18435969 10269578(55.7) 6599521(35.8) 1566870(8.5)
Sex
Men (n = 1285) 9197400 4392250(47.8) 3868773(42.1) 936377(10.1)
Women (n = 1319) 9238569 5877328(63.6) 2730748(29.6) 630493(6.8)
Abbreviation: IFG impaired fasting glucose; DM diabetes; ADA American Diabetes Association; FPG fasting plasma glucose.
Weighted frequency (based on sample weights).
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ited a 1.44 (95% CI = 1.43–1.44), 2.74 (95% CI = 2.73–2.75),
and 1.63 (95% CI = 1.63–1.64) higher probability of IFG,
respectively. Additionally, the likelihood of IFG was 1.42
(95% CI = 1.42–1.43) and 1.17 (95% CI = 1.16–1.17) greater
for participants with hypertension or hyperlipidemia than
for participants without such conditions. In addition,
separate analyses of the data for men and women show
that crucial shared variables influenced IFG values.
Discussion
The research participants were Taiwanese adults aged
over 19 years. For this investigation, we adopted a cross-
sectional research design and stratified multistage cluster
sampling method. Thus, the results are probably suffi-
ciently representative of the status of IFG among adults
in Taiwan. The first objective of this research was to
understand the prevalence of IFG among adults in
Taiwan. The findings indicate a prevalence rate of 35.8%Figure 1 Prevalence of impaired fasting glucose by sex according to(according to the ADA-revised diagnostic threshold for
IFG, ie, 100–125 mg/dl). As shown in Table 1, the preva-
lence of IFG in Taiwan exceeded that in South Korea
(23.9%) [13], and was similar to that observed in Wuxi
City, China (33.3%). These findings were based on the
ADA-revised diagnostic threshold [18]. If the previous
threshold for a diagnosis of IFG (ie, 110–125 mg/dl) is
used for calculation, the prevalence of IFG in Taiwan is
10.5% (Table 1), which is similar or even lower than that
of other countries (eg, 10.0% in the United States, 11.8%
in Denmark, and 17.3% in Sweden) calculated using the
previous diagnostic threshold [5,27]. In this investiga-
tion, we used the 2005–2008 NAHSIT to conduct data
analysis. The prevalence of IFG in the aforementioned
nations was investigated for years 2001 to 2004. Only
the investigation of IFG prevalence in Wuxi City,
China, examined data for 2007, which was the same
year analyzed in this research. The factors that may
contribute to the disparate prevalence of IFG in variousage group.
Table 2 Comparison of the levels of age, lipids, BP, BMI




Total cholesterol (mg/dl) 184.3±34.3 194.2±37.6*
Triglycerides (mg/dl) 98.9±61.4 138.7±111.0*
LDL (mg/dl) 115.6±32.4 124.0±36.2*
HDL (mg/dl) 57.2±14.6 51.2±13.9*
Systolic blood pressure (mmHg) 106.6±13.1 116.5±17.1*
Diastolic blood pressure (mmHg) 66.8±10.2 72.5±11.3*
Body mass index (Kg/m2) 22.5±3.4 25.0±3.7*
Waist circumference (cm) 76.4±9.5 84.3±9.9*
Men≥ 90 cm 80.1±8.9 86.7±9.0*
Women≥ 80 cm 73.7±8.9 80.9±10.2*
Overweight (%) 21.4 31*
Obesity (%) 9.1 27. 8*
Abdominal obesity (%) 17.8 43.2*
Hypertension (%) 7.5 23.7*
Hyperlipidemia (%) 38.5 57.4*
Data are means ± SD or n (%). *P < 0.01.








BMI < 24 1.00
27 > BMI≥ 24 (Overweight) 1.44*(1.43-1.44)











Logistic regression: associated risk factors were selected stepwise in model taking I
BMI group, abdominal obesity, hypertension, and hyperlipidemia.
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vious studies of IFG prevalence conducted on various
workplaces and regions in Taiwan [7,19], one study in-
vestigated a large-scale database comprising physical
examination data of civil servants from 1989 to 1992,
and calculated an IFG prevalence of 27.7% for that
period [7], which is considerably lower than the rate
determined in this investigation.
In this research, we investigated the distribution of
IFG prevalence according to sex and found that the
prevalence of IFG among men exceeded that among
women. A similar phenomenon was observed abroad
[12,13,16]. In addition, the trend of diabetes prevalence
in Taiwan shows variations according to sex; that is, the
incidence of diabetes was higher among men than
among women [2]. Variations according to age were also
observed. Specifically, below 65 years of age, men exhib-
ited a higher prevalence of IFG compared to women.
We also found that below 65 years of age, men exhibited
a higher overweight/obesity prevalence compared with
women, although the prevalence among women in-
creased with age and showed a continuous rise among
elderly women. IFG is significantly correlated with over-
weight and obesity. Over the age of 65, IFG prevalence
among women was higher than that among men. This is
presumably because women have a comparatively longer
lifespan, and may also be influenced by the effects ofse from multiple logistic regression model
Men Women











FG as a dependent variable. Variables included in the model were: sex, age,
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prevalence was observed among men aged between 19
and 40 years, which is a warning sign that requires sub-
stantial attention. For young men, long-term exposure to
IFG risks can lead to the early emergence or develop-
ment of diabetes-induced pathological capillary changes.
The second research objective was to explore the crucial
variables that influence the prevalence of IFG among adults
in Taiwan. The results of multiple logistic regression ana-
lysis show that the following variables are considerably as-
sociated with IFG: sex, age, overweight (27 > BMI ≥ 24),
obesity (BMI ≥ 27), abdominal obesity (ie, a waist circum-
ference of 90 cm for men ≥ and ≥ 80 cm for women),
hypertension, and hyperlipidemia. This finding is similar to
that reported in previous literature [12,16,18,19]. People
with IFG have higher cardiovascular risks than people with
normal FPG. In addition, clinical research has shown that
IFG leads to a collection of symptoms (eg, metabolic syn-
drome) and is considerably associated with the risk of dia-
betes [28,29]. The results of this research support those of
previous studies conducted in various countries with differ-
ent ethnic groups by identifying similar factors that correl-
ate significantly with IFG. This further confirms that IFG is
frequently comorbid with the risk factors for cardiovascu-
lar disease, such as hypertension and dyslipidemia.
In addition, we found that IFG is considerably associated
with overweight (27 > BMI ≥ 24), obesity (BMI ≥ 27), and
abdominal obesity. Considering that IFG is typically co-
morbid with the risk factors for cardiovascular disease, in-
cluding hypertension and dyslipidemia, and highly
associated with a 10-y diabetes risk, obesity can further in-
crease these risks [19,30]. Obesity has become increasingly
prevalent in Taiwan because of economic growth and life-
style changes. The following findings were based on the
results of 2 domestic nutrition and health surveys con-
ducted from 1993 to 1996 and from 2005 to 2008: The
average waist circumference increased by 5.1 cm for adult
men and by 4 cm for adult women, and the prevalence of
overweight/obesity increased by 17.6% for adult men and
by 2.4% for adult women. This shows that the prevalence
of overweight and obesity has increased for both men and
women in Taiwan, although a greater increase is observed
for men [31]. Consequently, active efforts are necessary to
develop health promotion programs for this specific popu-
lation group, using lifestyle changes as the primary treat-
ment method for preventing or delaying diabetes.
Although IFG typically manifests without clinical symp-
toms, the associated risk of type 2 diabetes is relatively
high, and the risk of cardiovascular diseases is increased.
Numerous previous studies investigating the risk factors
and epidemiology of diabetes have reported that by the
time diabetes is diagnosed, the person’s pancreatic β cells
typically exhibit a 50% decline in function [32]. Further-
more, diabetes is a chronic disease of slow progression.The risks of cardiovascular disease and stroke are in-
creased if blood glucose levels are slightly higher than nor-
mal, yet below the diagnostic threshold for diabetes [7].
However, IFG is a clinical condition and considered re-
versible [33]. Research regarding IFG-related factors is
crucial for initiating prevention and treatment efforts dur-
ing the early preventive stage, and for encouraging the
provision of adequate attention and early interventions to
effectively prevent or delay the development of diabetes
and relevant complications.
Several limitations of this research must be addressed.
First, this research sampled only adults aged ≥ 19 years;
thus, the results cannot be extrapolated to other age
groups. Second, although the results are based on a ran-
dom sampling of national data, they only apply to the
population of Taiwan. Finally, the data collected using
the cross-sectional survey was only for the specific
period the survey was conducted, and cannot be used for
predictions or as evidence of causality.
Conclusion
IFG among adults in Taiwan is a health concern that re-
quires substantial attention. Current treatment and preven-
tion methods primarily focus on identifying, preventing,
and controlling various risk factors. Therefore, we recom-
mend the following strategies: (1) Target relatively younger
population groups, especially men aged between 19 and
40 years who are overweight and obese, with the provision
of appropriate healthy lifestyle counseling and services. (2)
Provide suitable screening for elderly people to identify un-
diagnosed IFG cases and provide early intervention and
treatment. Thus, the goals of preventing the high-risk
group from developing diabetes, and preventing the low-
risk group from becoming high risk can be achieved. (3)
Future longitudinal follow-up studies should be conducted
to provide insights into the causes and effects of IFG,
thereby facilitating a more accurate understanding and su-
perior control of IFG incidence in Taiwan. Furthermore,
the results of such research can provide beneficial data as a
reference for public health-related decisions.
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